BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 17074633)

  • 21. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
    Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
    St John Sutton MG; Plappert T; Abraham WT; Smith AL; DeLurgio DB; Leon AR; Loh E; Kocovic DZ; Fisher WG; Ellestad M; Messenger J; Kruger K; Hilpisch KE; Hill MR;
    Circulation; 2003 Apr; 107(15):1985-90. PubMed ID: 12668512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy.
    Duckett SG; Ginks M; Shetty AK; Bostock J; Gill JS; Hamid S; Kapetanakis S; Cunliffe E; Razavi R; Carr-White G; Rinaldi CA
    J Am Coll Cardiol; 2011 Sep; 58(11):1128-36. PubMed ID: 21884950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchronization therapy.
    Bogaard MD; Houthuizen P; Bracke FA; Doevendans PA; Prinzen FW; Meine M; van Gelder BM
    Eur J Heart Fail; 2011 Oct; 13(10):1126-32. PubMed ID: 21791536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy.
    Murphy RT; Sigurdsson G; Mulamalla S; Agler D; Popovic ZB; Starling RC; Wilkoff BL; Thomas JD; Grimm RA
    Am J Cardiol; 2006 Jun; 97(11):1615-21. PubMed ID: 16728225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The left ventricular lead electrical delay predicts response to cardiac resynchronisation therapy.
    Zhang H; Dai Z; Xiao P; Pan C; Zhang J; Hu Z; Chen S
    Heart Lung Circ; 2014 Oct; 23(10):936-42. PubMed ID: 24996391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy.
    Gold MR; Yu Y; Singh JP; Stein KM; Birgersdotter-Green U; Meyer TE; Seth M; Ellenbogen KA
    Heart Rhythm; 2013 Jul; 10(7):988-93. PubMed ID: 23499621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
    Zanon F; Baracca E; Pastore G; Fraccaro C; Roncon L; Aggio S; Noventa F; Mazza A; Prinzen F
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):377-83. PubMed ID: 24668162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    Spragg DD; Dong J; Fetics BJ; Helm R; Marine JE; Cheng A; Henrikson CA; Kass DA; Berger RD
    J Am Coll Cardiol; 2010 Aug; 56(10):774-81. PubMed ID: 20797490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximum derivative of left ventricular pressure predicts cardiac mortality after cardiac resynchronization therapy.
    Suzuki H; Shimano M; Yoshida Y; Inden Y; Muramatsu T; Tsuji Y; Tsuboi N; Hirayama H; Shibata R; Murohara T
    Clin Cardiol; 2010 Dec; 33(12):E18-23. PubMed ID: 21184541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of ventricular activation pattern and acute hemodynamics during multipoint left ventricular pacing.
    Menardi E; Ballari GP; Goletto C; Rossetti G; Vado A
    Heart Rhythm; 2015 Aug; 12(8):1762-9. PubMed ID: 25916565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration.
    D'Onofrio A; Botto G; Mantica M; LA Rosa C; Occhetta E; Verlato R; Molon G; Ammendola E; Villani GQ; Bongiorni MG; Bianchi V; Gelmini GP; Valsecchi S; Ciardiello C
    J Cardiovasc Electrophysiol; 2014 May; 25(5):500-506. PubMed ID: 24494797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiating Electromechanical From Non-Electrical Substrates of Mechanical Discoordination to Identify Responders to Cardiac Resynchronization Therapy.
    Lumens J; Tayal B; Walmsley J; Delgado-Montero A; Huntjens PR; Schwartzman D; Althouse AD; Delhaas T; Prinzen FW; Gorcsan J
    Circ Cardiovasc Imaging; 2015 Sep; 8(9):e003744. PubMed ID: 26338877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interlead distance and left ventricular lead electrical delay predict reverse remodeling during cardiac resynchronization therapy.
    Merchant FM; Heist EK; Nandigam KV; Mulligan LJ; Blendea D; Riedl L; McCarty D; Orencole M; Picard MH; Ruskin JN; Singh JP
    Pacing Clin Electrophysiol; 2010 May; 33(5):575-82. PubMed ID: 20070543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated estimated pulmonary artery systolic pressure is associated with an adverse clinical outcome in patients receiving cardiac resynchronization therapy.
    Stern J; Heist EK; Murray L; Alabiad C; Chung J; Picard MH; Semigran MJ; Ruskin JN; Singh JP
    Pacing Clin Electrophysiol; 2007 May; 30(5):603-7. PubMed ID: 17461868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of interventricular conduction delay to predict clinical response with cardiac resynchronization therapy.
    Gold MR; Yu Y; Wold N; Day JD
    Heart Rhythm; 2017 Dec; 14(12):1748-1755. PubMed ID: 29195547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of intraoperative electrical parameters in predicting reverse remodelling after cardiac resynchronization therapy and correlation with interventricular mechanical dyssynchrony.
    Zucchelli G; Soldati E; Di Cori A; De Lucia R; Segreti L; Solarino G; Borelli G; Di Bello V; Bongiorni MG
    Europace; 2010 Oct; 12(10):1453-9. PubMed ID: 20663782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.